|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Doogan Declan
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-04-12 Sale |
2019-04-16 7:23 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
88,825 | $58.42 | $5,189,444 | 976,002 (Direct Indirect) |
View |
| 2019-03-22 Sale |
2019-03-26 6:30 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
11,175 | $53.69 | $600,000 | 1,020,651 (Direct Indirect) |
View |
| 2019-02-27 Sale |
2019-03-01 5:59 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
101,024 | $46.26 | $4,672,922 | 1,076,597 (Direct Indirect) |
View |
| 2019-02-22 Sale |
2019-02-26 5:44 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
76,898 | $44.9 | $3,452,588 | 1,099,981 (Direct Indirect) |
View |
| 2019-02-15 Sale |
2019-02-20 5:40 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
2,078 | $45.48 | $94,509 | 1,115,324 (Direct Indirect) |
View |
| 2019-02-12 Sale |
2019-02-14 4:42 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
40,000 | $44.31 | $1,772,307 | 1,122,160 (Direct Indirect) |
View |
| 2018-12-03 Sale |
2018-12-06 4:26 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
40,000 | $41.95 | $1,678,000 | 1,156,002 (Direct Indirect) |
View |
| 2018-06-04 Sale |
2018-06-06 4:19 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
89,216 | $35.25 | $3,145,112 | 1,245,765 (Direct Indirect) |
View |
| 2018-05-30 Sale |
2018-06-01 5:29 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
110,784 | $35.03 | $3,881,056 | 1,395,160 (Direct Indirect) |
View |
| 2018-01-16 Sale |
2018-01-18 6:57 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
128,058 | $26.95 | $3,451,297 | 1,487,027 (Direct Indirect) |
View |
| 2018-01-10 Sale |
2018-01-12 7:00 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
121,942 | $26.78 | $3,265,537 | 1,276,131 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-05-21 Option Award |
2019-05-23 6:33 pm |
N/A 2029-05-20 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
18,000 | $61.76 | 18,000 (Direct) |
View |
| 2018-05-01 Option Award |
2018-05-03 5:25 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
18,000 | $28.76 | 18,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 23 May 2019 22:33:12 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |